[1]
Albareda, N. and Zeichner, J. 2017. A Randomized Vehicle-Controlled Trial to Assess the Efficacy, Safety, and Tolerability of Ozenoxacin 1% Cream in 465 Patients 2 Years and Older with Impetigo. SKIN The Journal of Cutaneous Medicine. 1, 3.1 (Oct. 2017), s104. DOI:https://doi.org/10.25251/skin.1.supp.103.